EUROMENE

EUROMENE stands for European ME Network, also called European Network on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome started by the Cooperation In Science And Technology (COST) Association, an international not-for-profit organization. Funding was approved for four years and may be extended longer upon approval. COST refers the formation of EUROMENE as COST Action 15111 or CA15111.

The official start date of the organization is 21 April 2016 and is funded until 20 April 2020 unless extension is approved.

Goals
The following objectives were listed on the memorandum for the implementation of the network:

"Research Coordination procedures  with   pilot   studies   in   selected   locations;   develop   a   geographical   mapping   of   ME/CFS epidemiology involving correlations with other mapped information biomarkers for ME/CFS capable to evaluation of various infections and immunological disorders as causal factors or comorbidities identification  of  relatively  homogenous  sets  of  patients,  who  can  be  studied  to  identify  pathogenesis mechanisms,  biomarkers  and  disease  process  in  a  stratified  way,  as  well  as  to  be  compared  with  other researched populations the disease (SMEs), in the pharmaceutical, biotechnology and ICT industries in each participating country to develop collaborative research and innovation proposals"
 * Develop strategies to collect population-based data on the prevalence of ME/CFS, including standardized
 * Promote co-operation  and  involvement  of  research  groups  with  an  objective  to  assess  potential
 * Define a  standardized  clinical  diagnosis  for  ME/CFS  for  clinicians  and  researchers  that  allows  the
 * Coordinate efforts to determine the social impact of ME/CFS and to appraise the economic damage from
 * Establish communication  links  with  industrial  organisations,  especially  small/medium-sized  enterprise

"Capacity Building and special translational research skills; Demonstrate ME/CFS as a promising field for carrier development in science ME/CFS, -omics and bioinformatics, translational research in ME/CFS by involving relevant stakeholders, interested researchers, ECIs and clinicians, and organizing working groups, seminars, training schools, and Short-Term Scientific Missions (STSMs) involvement"
 * Integrate Early Career Investigators (ECI) into network activities, providing optimal diffusion of knowledge
 * Foster knowledge exchange on use of synchronised diagnostic criteria and management of research in
 * Provide update  in  novel  ME/CFS  knowledge  via  short  training  events  with  an  efficient  participant

Management Committee
The following are listed as being participants of the COST Action CA15111/EUROMENE :
 * Chair - Professor Modra Murovska, Riga Stradins University, Riga, Latvia
 * Vice Chair - Dr. Eliana Lacerda, London School of Hygiene & Tropical Medicine, London, UK
 * Members - Professor Mira Meeus, Universiteit Antwerpen, Belgium; Dr. Els Tobback, University Hospital Ghent, Belgium; Professor Evelina Shikova-Lekova, National Center of Infectious and Parasitic Diseases, Bulgaria; Dr. Henrik Nielsen, PrivatHospitalet Danmark, Denmark; Professor Jerome Authier, Paris Est-Creteil University, France; Professor Carmen Scheibenbogen, Charite, Germany; Professor Thomas Harrer, Universitatsklinikum Erlangen, Germany; Dr Lorenzo Lorusso, A.O. Mellino Mellini, Italy; Professor Enrica Capelli, Italy; Dr. Uldis Berkis, Riga Stradins University, Latvia; Professor Anne Marit Mengshoel, University of Oslo, Norway; Dr. Elin B. Strand, Oslo University Hospital HF CFS/ME Centre, Norway; Dr. Magdalena Budisteanu, "Prof. Dr. Alex. Obregia" Clinical Hospital of Psychiatry, Romania; Dr. Carmen Adella Sirbu, Central Military Emergency Hospital, Romania; Dr. Slobodan Sekulic, Medical Faculty Novi Sad, Serbia; Dr. Jesus Castro-Marrero, Vall d'Hebron University Hospital, Spain; Dr. Julia Blanco, Fundacio Institut Germans trias i Pujol, Spain; Dr. Eliana Lacerda, London School of Hygiene & Tropical Medicine, London, UK; Professor Derek Pheby, Buckinghamshire New University, United Kingdom
 * Member Substitutes - Dr Madlen Lobel, Charite University Medicine Berlin, Germany; Mr. Babak Asadi-Azarbaijani, Aker Hospital, Norway; Dr. Ingrid Bergliot Helland, Oslo University Hospital, Norway; Dr. Jose Alegre-Martin, Vall d'Hebron University Hospital, Spain; Professor Jordi Miro, Universitat Rovira i Virgili, Spain; Professor Jonathan Edwards, University College London, UK; Dr. Luis Nacul, London School of Hygiene and Tropical Medicine, UK

Learn More

 * Memorandum of  Understanding  for  the  implementation  of  the  COST  Action “European  Network  on  Myalgic  Encephalomyelitis/Chronic  Fatigue  Syndrome” (EUROMENE) CA15111